LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System

March 28, 2018 by Website Admin in

LivaNova today announced the launch and enrollment of the first patient in a clinical study to examine the use of LivaNova’s new Microburst Vagus Nerve Stimulation Therapy® (“VNS Therapy”) System.

Tweet

Share

Pin it

Previous StoryMoleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials Next StoryLivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients